Acadia Healthcare (NASDAQ:ACHC) Lowered to “Sell” at StockNews.com

StockNews.com cut shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a sell rating in a research note issued to investors on Tuesday morning.

ACHC has been the subject of a number of other research reports. Royal Bank of Canada reissued an outperform rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Monday, March 4th. Bank of America cut their target price on shares of Acadia Healthcare from $105.00 to $90.00 and set a buy rating on the stock in a research note on Thursday, May 2nd. Mizuho decreased their price target on shares of Acadia Healthcare from $84.00 to $70.00 and set a neutral rating for the company in a research report on Friday, May 3rd. Cantor Fitzgerald reissued a neutral rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Finally, TheStreet raised Acadia Healthcare from a c rating to a b- rating in a research report on Monday, March 4th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of Moderate Buy and an average target price of $87.56.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $63.58 on Tuesday. The firm has a market capitalization of $5.90 billion, a price-to-earnings ratio of -454.11, a price-to-earnings-growth ratio of 1.98 and a beta of 1.31. The company has a 50 day moving average price of $72.26 and a 200 day moving average price of $76.82. Acadia Healthcare has a one year low of $63.10 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. During the same period last year, the company posted $0.75 EPS. The business’s quarterly revenue was up 9.1% on a year-over-year basis. Sell-side analysts anticipate that Acadia Healthcare will post 3.53 EPS for the current year.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Teacher Retirement System of Texas boosted its holdings in shares of Acadia Healthcare by 10.3% in the 3rd quarter. Teacher Retirement System of Texas now owns 29,551 shares of the company’s stock valued at $2,078,000 after buying an additional 2,766 shares during the period. California Public Employees Retirement System boosted its stake in Acadia Healthcare by 112.6% in the third quarter. California Public Employees Retirement System now owns 368,382 shares of the company’s stock valued at $25,901,000 after acquiring an additional 195,130 shares during the period. NewSquare Capital LLC grew its holdings in shares of Acadia Healthcare by 10.3% during the third quarter. NewSquare Capital LLC now owns 46,503 shares of the company’s stock valued at $3,270,000 after purchasing an additional 4,358 shares during the last quarter. Jackson Creek Investment Advisors LLC acquired a new stake in shares of Acadia Healthcare during the 3rd quarter worth approximately $757,000. Finally, Sivik Global Healthcare LLC boosted its position in Acadia Healthcare by 25.0% during the 3rd quarter. Sivik Global Healthcare LLC now owns 75,000 shares of the company’s stock valued at $5,273,000 after purchasing an additional 15,000 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.